Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethan J Rowin

Showing results (11-20 of 194) with videos related to

Pageof 20
Sort By:
Trends in Cardiovascular Medicine|August 26, 2024
Editorial commentary: Is it finally prime time for artificial intelligence to improve the care of patients with hypertrophic cardiomyopathy?Richard T Carrick, Ethan J Rowin
Trends in Cardiovascular Medicine|July 26, 2018
Editorial commentary: Role of cardiac magnetic resonance imaging in the evaluation of amyloidosisCharles As Miller, Ethan J Rowin
Journal of the American College of Cardiology|April 30, 2021
Evaluating Histopathology to Improve Our Understanding of Hypertrophic CardiomyopathyEthan J Rowin, Michael A Fifer
European Heart Journal. Cardiovascular Imaging|July 7, 2022
Cardiovascular magnetic resonance for screening in hypertrophic cardiomyopathy: the new family planEthan J Rowin, Martin S Maron
JACC. Heart Failure|July 28, 2022
Refining Endpoint Measures in Clinical Trials for Hypertrophic Cardiomyopathy: The Emerging Role of Patient-Reported OutcomesEthan J Rowin, Martin S Maron
Circulation. Cardiovascular Imaging|June 18, 2015
Evidence for Left Ventricular Outflow Tract Obstruction With Minimal Septal Hypertrophy: The Case Grows Stronger for a Multimodality Imaging Strategy for Hypertrophic CardiomyopathyEthan J Rowin, Martin S Maron
The New England Journal of Medicine|December 17, 2025
Aficamten Monotherapy for Hypertrophic CardiomyopathyHisham Ahamed, Steve R Ommen, Ethan J Rowin
JACC. Heart Failure|May 5, 2018
Global Burden of Hypertrophic CardiomyopathyBarry J Maron, Ethan J Rowin, Martin S Maron
The Canadian Journal of Cardiology|November 10, 2019
The ESC Risk Score Is Less Reliable than ACC/AHA Risk Factors in Hypertrophic Cardiomyopathy: When Sensitivity Trumps SpecificityMartin S Maron, Ethan J Rowin, Barry J Maron
The American Journal of Cardiology|December 19, 2012
Reply: To PMID 23245842Ethan J Rowin, Barry J Maron, Martin S Maron
Pageof 20

Showing results (11-20 of 194) with videos related to

Sort By:
Pageof 20
Trends in Cardiovascular Medicine|August 26, 2024
Editorial commentary: Is it finally prime time for artificial intelligence to improve the care of patients with hypertrophic cardiomyopathy?Richard T Carrick, Ethan J Rowin
Trends in Cardiovascular Medicine|July 26, 2018
Editorial commentary: Role of cardiac magnetic resonance imaging in the evaluation of amyloidosisCharles As Miller, Ethan J Rowin
Journal of the American College of Cardiology|April 30, 2021
Evaluating Histopathology to Improve Our Understanding of Hypertrophic CardiomyopathyEthan J Rowin, Michael A Fifer
European Heart Journal. Cardiovascular Imaging|July 7, 2022
Cardiovascular magnetic resonance for screening in hypertrophic cardiomyopathy: the new family planEthan J Rowin, Martin S Maron
JACC. Heart Failure|July 28, 2022
Refining Endpoint Measures in Clinical Trials for Hypertrophic Cardiomyopathy: The Emerging Role of Patient-Reported OutcomesEthan J Rowin, Martin S Maron
Circulation. Cardiovascular Imaging|June 18, 2015
Evidence for Left Ventricular Outflow Tract Obstruction With Minimal Septal Hypertrophy: The Case Grows Stronger for a Multimodality Imaging Strategy for Hypertrophic CardiomyopathyEthan J Rowin, Martin S Maron
The New England Journal of Medicine|December 17, 2025
Aficamten Monotherapy for Hypertrophic CardiomyopathyHisham Ahamed, Steve R Ommen, Ethan J Rowin
JACC. Heart Failure|May 5, 2018
Global Burden of Hypertrophic CardiomyopathyBarry J Maron, Ethan J Rowin, Martin S Maron
The Canadian Journal of Cardiology|November 10, 2019
The ESC Risk Score Is Less Reliable than ACC/AHA Risk Factors in Hypertrophic Cardiomyopathy: When Sensitivity Trumps SpecificityMartin S Maron, Ethan J Rowin, Barry J Maron
The American Journal of Cardiology|December 19, 2012
Reply: To PMID 23245842Ethan J Rowin, Barry J Maron, Martin S Maron
Pageof 20